SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-067447
Filing Date
2019-03-07
Accepted
2019-03-07 17:19:33
Documents
6
Period of Report
2019-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d720037d8k.htm 8-K 20731
2 EX-1.1 d720037dex11.htm EX-1.1 183868
3 EX-5.1 d720037dex51.htm EX-5.1 24603
4 GRAPHIC g7200371.jpg GRAPHIC 6642
5 GRAPHIC g7200372.jpg GRAPHIC 83007
6 GRAPHIC g720037g0307055600024.jpg GRAPHIC 8053
  Complete submission text file 0001193125-19-067447.txt   365427
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 19666771
SIC: 2834 Pharmaceutical Preparations